FDA 483 - Patheon Softgels Inc. - July 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of ThermoFisher Scientific dba Patheon Softgels Inc in High Point, NC, from July 7-17, 2025, revealed significant deficiencies in quality control and manufacturing documentation. Observations included a failure to follow established cleaning and maintenance procedures for equipment, incomplete Quality Control Microbiology Laboratory notebooks lacking QA signatures and timely review, and deficient batch production records that did not accurately document manufacturing steps. These issues indicate a lack of adherence to established procedures and proper record-keeping practices.
ID · 4f88737c-2d35-45cb-8564-ff4184f245b2